Jump to: Sensor transition details Benefits How to transition your patients FAQs
The FreeStyle Libre 2 and FreeStyle Libre 3 sensors will be discontinued in September. Transition all your patients to the FreeStyle Libre 3 Plus and FreeStyle Libre 2 Plus sensor.
To deliver innovation that makes diabetes management easier, we’re making changes to streamline your patients’ journey to our most advanced technology—the FreeStyle Libre 3 Plus and FreeStyle Libre 2 Plus sensors.
The FreeStyle Libre 2 and FreeStyle Libre 3 sensors will be discontinued September 30, 2025.
Patients using these sensors will require a new prescription.
In addition to all the great benefits you’ve come to expect—including proven accuracy1,2, small size, and ease of use3,*4–5—here are some advanced features that set the FreeStyle Libre 3 Plus and FreeStyle Libre 2 Plus sensors apart.
Extended wear time
Up to 15 days. Just two sensors a month.
Insulin pump compatibility
with select automated insulin delivery systems.
Greater patient reach
Suitable for children 2 years and older.
The most affordable
CGM for your patients†6.
CGM = continuous glucose monitor(ing)
For current FreeStyle Libre 3 users:
FreeStyle Libre 3 Plus sensor: NRC# 57599-0844-00
Optional FreeStyle Libre 3 reader: NRC# 57599-0820-00
TAA Compliant FreeStyle Libre 3 reader: NRC# 57599-0842-00
Available at participating pharmacies‡
For current FreeStyle Libre 2 users:
FreeStyle Libre 2 Plus sensor: NRC# 57599-0835-00
Optional FreeStyle Libre 2 reader: NRC# 57599-0803-00
TAA Compliant FreeStyle Libre 2 reader: NRC# 57599-0805-00
Available at participating durable medical equipment (DME) suppliers§
A new prescription for a FreeStyle Libre 3 Plus or FreeStyle Libre 2 Plus sensor may require a prior authorization (PA) depending on your patient's coverage plan.
A prior authorization (PA) can help most of your commercially insured patients save over 50% every month for their FreeStyle Libre 3 Plus or FreeStyle Libre 2 Plus sensor¶6.
Yes. If you have patients who are currently using the FreeStyle Libre 2 or FreeStyle Libre 3 sensors, you will need to write them new prescriptions for the FreeStyle Libre 3 Plus or FreeStyle Libre 2 Plus sensor. See these helpful patient transition details to determine which sensor is appropriate for which patients.
FreeStyle Libre 2 and FreeStyle Libre 3 sensors will continue to be available through September 30, 2025.
The FreeStyle Libre 3 Plus and FreeStyle Libre 2 Plus sensors are widely available to patients through retail pharmacy, DME suppliers, mail order companies, and government pharmacies.
FreeStyle Libre 3 Plus sensors have the same Medicare coverage as FreeStyle Libre 3 sensors. They are widely covered for those managing diabetes with insulin‖6,7.
FreeStyle Libre 2 Plus sensors have the same Medicare coverage as FreeStyle Libre 2 sensors. They are widely covered for those managing diabetes with insulin‖6,7.
No. Your practice can continue to use any FreeStyle Libre 2 or FreeStyle Libre 3 sensor samples within the expiration date. You do not need to ship back any unused sensors for disposal.
If you or your patients have any questions about this change, please don’t hesitate to reach out to our Customer Support Team at 855-632-8658, Monday through Friday, 8 AM to 8 PM Eastern Time; excluding holidays.
FreeStyle Libre 3 system is cleared to be used by children 4 years and older with Libre 3 sensor and 2 years and older with Libre 3 Plus sensor.
FreeStyle Libre 2 system is cleared to be used by children 4 years and older with Libre 2 sensor and 2 years and older with Libre 2 Plus sensor.
Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.
* Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 2 and FreeStyle Libre 3 systems, as feature sets are similar.
† Based on prescription claims for commercially insured patients starting on the FreeStyle Libre personal CGM systems compared to competitor CGMs. Does not include Medicare, Medicaid, uninsured, and other federal or state healthcare program patients. The actual cost to patients may or may not be lower than other CGM systems, depending on the amount covered by insurance, if any.
‡ Participating pharmacies are subject to change without notice. Product availability may vary by retailer.
§ DMEs are subject to change without notice.
‖ Patients must meet eligibility coverage criteria.
¶ Based on prescription claims for commercially insured patients starting on the FreeStyle Libre personal CGM system compared to competitor CGMs. Does not include Medicare, Medicaid, uninsured, and other federal or state healthcare program patients.
References: 1. FreeStyle Libre 2 User's Manual. 2. FreeStyle Libre 3 User's Manual. 3. Alva, Shridhara, et al. "Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System." Diabetes Therapy 14, no. 4 (2023): 767–776. https://doi.org/10.1007/s13300-023-01385-6. 4. Haak, Thomas, et al. "Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicentre, Open-Label Randomised Controlled Trial." Diabetes Therapy 8, no. 1 (2017): 55–73. https://doi.org/10.1007/s13300-016-0223-6. 5. Campbell, Fiona, et al. "Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study." Pediatric Diabetes 19, no. 7 (2018): 1294–1301. https://doi.org/10.1111/pedi.12735. 6. Data on file. Abbott Diabetes Care, Inc. 7. Local Coverage Determination (LCD) L33822, Glucose Monitors. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33822.
ADC-105503 v1.0
Important Safety Information
FreeStyle Libre 14 day, FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose reading and alarms (if enabled) do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855‑632‑8658 or FreeStyleLibre.us for safety info.
The product images are for illustrative purposes only.
The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.
No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.
This website and the information contained herein is intended for use by residents of the United States.
ADC-45115 v19.0
The "Yes" link below will take you out of the Abbott Laboratories family of websites. Links which take you out of Abbott Laboratories worldwide web sites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the contents of any such site or any further links from such site. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott Laboratories.
Do you wish to leave this site?
